The orthopedic medical device industry has a $25 – $30 billion/yr. impact on U.S. health care.
Five orthopedic medical device companies have established an oligopoly.
Physician-owned medical device distributorships (PODs) have emerged as both an alternative distribution model and the only form of real competition to help lower prices.
Most PODs functioning today follow no standards for disclosure and don’t necessarily provide meaningful cost savings to hospitals.
Only strict standards, such as those established by the AASD, protect patients and hospitals, assure proven cost savings (often exceeding 30%), guarantee full transparency, and help ensure competition.